Radiotherapy Delivery in Deep Inspiration for Pediatric Patients—Final Results of the Phase II Feasibility Study <i>TEDDI</i>
The TEDDI trial demonstrated the feasibility and safety of DIBH in pediatric radiotherapy. High compliance with the procedure and favorable dosimetric outcomes support the use of DIBH to reduce long-term toxicity risks in this population.
Authors
- Laura Ann Rechner (ORCID: https://orcid.org/0000-0002-0623-4495)
- Anni Young Lundgaard (ORCID: https://orcid.org/0000-0001-5800-888X)
- Leila Vaalavirta
- Daniella Elisabet Østergaard (ORCID: https://orcid.org/0000-0002-1848-5339)
- Marianne Aznar (ORCID: https://orcid.org/0000-0001-6452-0310)
- Danijela Dejanović (ORCID: https://orcid.org/0000-0001-5540-8933)
- Miia Mokka
- Hanne Rose (ORCID: https://orcid.org/0000-0002-8391-4128)
- Lisa Lyngsie Hjalgrim (ORCID: https://orcid.org/0000-0001-5186-3365)
- Jolanta Hansen
- Peder Skov Wehner
- Maja Vestmø Maraldo
Institutions
- University of Copenhagen (DK)
- Manchester Academic Health Science Centre (GB)
- Helsinki University Hospital (FI)
- Odense University Hospital (DK)
- Turku University Hospital (FI)
- Aarhus University Hospital (DK)
- Copenhagen University Hospital (DK)
- Rigshospitalet (DK)
- University of Manchester (GB)
Publication Details
- Journal
- Pediatric Blood & Cancer
- Published
- 2026-02-09
- DOI
- https://doi.org/10.1002/1545-5017.70100
- Primary Topic
- Advanced Radiotherapy Techniques
- Type
- article
- Field-Weighted Citation Impact
- 0.00
Funders
- National Institute for Health and Care Research
- Gentofte Hospital
- Turun Yliopistollinen Keskussairaala
- Manchester Biomedical Research Centre
- Engineering and Physical Sciences Research Council